Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
58.47
+1.19 (2.07%)
May 4, 2026, 10:53 AM EDT - Market open
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
158.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 114.20M |
| Black Diamond Therapeutics | 70.00M |
| Alps Group | 3.74M |
| Oramed Pharmaceuticals | 2.00M |
| Kazia Therapeutics | 1.27M |
| Molecular Partners AG | 856.30K |
| InflaRx | 34.44K |
SPRB News
- 3 hours ago - Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations - Business Wire
- 13 days ago - Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 13 days ago - Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 7 weeks ago - Spruce Biosciences Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Spruce Biosciences Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates - Business Wire
- 2 months ago - Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer - Business Wire
- 2 months ago - Spruce Biosciences to Present at Upcoming Investor Conferences in March - Business Wire